EPS growth is an important number as it indicates the future prospects of Catasys. The EPS growth rate, as it is usually called, is typically displayed as a percentage, which at this time is hard to estimate, but revenue growth has been 5.60 % over the last twelve months. The higher the EPS growth rate, the higher the value that is added to shareholders and a good reflection on the performance of the management at Catasys.
Catasys is in the healthcare sector and health care providers industry. The company CEO is Terren S. Peizer. Catasys Inc is a healthcare services company, provides health services designed to assist health plans and employees to manage and treat their high cost substance dependence members through a network of healthcare providers and its employees.
Previous Intraday Performance:
The CATS shares had a previous change of 6.46% which opened at 10.98 and closed at 11.71. It moved to an intraday high of 12.19 and a low of 10.98.
SeekingAlpha: Catasys Inc. (CATS) CEO Terren Peizer on Q3 2018 Results – Earnings Call Transcript
Historical Performance:
Over the last five trading days, CATS shares returned 18.04% and in the past 30 trading days it returned 34.29%. Over three months, it changed 30.84%. In one year it has changed 206.54% and within that year its 52-week high was 14.29 and its 52-week low was 3.30. CATS stock is 254.85% above its 52 Week Low.
Our calculations result in a 200 day moving average of 7.43 and a 50 day moving average of 10.19. Right now, CATS stock is trading 57.56% above its 200 day moving average.
SeekingAlpha: Catasys Inc. (CATS) CEO Terren Peizer on Q3 2018 Results – Earnings Call Transcript
Liquidity:
The company has a market cap of $186.3m with 15.9m shares outstanding and a float of 1.7m shares. Trading volume was 80,480 shares and has experienced an average volume of 58,776 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for Catasys was -1.72 which ended on 31st of December 2017. Based on 1 analyst estimate, the estimated EPS for the next quarter is -0.29.
Below was the last reported quarterly earnings per share:
09-30-2018: -0.27
06-30-2018: -0.26
03-31-2018: -0.27
12-31-2017: -0.17
Indicators Also to Watch:
Based on the latest filings, there is 89.40% of insider ownership and 18.50% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.
I calculated the beta to be 1.31
SeekingAlpha: Apellis Pharma down 17% on hiccup in late-stage study of APL-2
Fundamental Numbers:
Based on last reported financials, the company’s return on assets is -178.17%, price-to-sales is 13.91 and price-to-book is 92.06.
Company Score Card:
Results are out of six:
2 : Growth Expectations Result
1 : Financial Safety Result
0 : Past Performance Result
0 : Valuation Result
0 : Dividend Safety Result
0 : Overall Result
Related Tags: Catasys, cats, Health Care Providers, Healthcare
